{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T20:38:51Z","timestamp":1793047131924,"version":"4.5.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,3,16]],"date-time":"2022-03-16T00:00:00Z","timestamp":1647388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,3,16]],"date-time":"2022-03-16T00:00:00Z","timestamp":1647388800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81974255"],"award-info":[{"award-number":["81974255"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81620108014"],"award-info":[{"award-number":["81620108014"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1007\/s10875-022-01218-4","type":"journal-article","created":{"date-parts":[[2022,3,16]],"date-time":"2022-03-16T17:04:35Z","timestamp":1647450275000},"page":"837-850","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Activated Phosphoinositide 3-Kinase \u03b4 Syndrome: a Large Pediatric Cohort from a Single Center in China"],"prefix":"10.1007","volume":"42","author":[{"given":"Luyao","family":"Qiu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjing","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuyun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuemei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfei","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuemei","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2054-8711","authenticated-orcid":false,"given":"Xiaodong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,16]]},"reference":[{"key":"1218_CR1","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1126\/science.1243292","volume":"342","author":"I Angulo","year":"2013","unstructured":"Angulo I, Vadas O, Gar\u00e7on F, Banham-Hall E, Plagnol V, Leahy TR, et al. Phosphoinositide 3-kinase \u03b4 gene mutation predisposes to respiratory infection and airway damage. Science. 2013;342:866\u201371.","journal-title":"Science"},{"key":"1218_CR2","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1084\/jem.20141759","volume":"211","author":"CL Lucas","year":"2014","unstructured":"Lucas CL, Zhang Y, Venida A, Wang Y, Hughes J, McElwee J, et al. Heterozygous splice mutation in PIK3R1 causes human immunodeficiency with lymphoproliferation due to dominant activation of PI3K. J Exp Med. 2014;211:2537\u201347.","journal-title":"J Exp Med"},{"key":"1218_CR3","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1038\/nri.2016.93","volume":"16","author":"CL Lucas","year":"2016","unstructured":"Lucas CL, Chandra A, Nejentsev S, Condliffe AM, Okkenhaug K. PI3K\u03b4 and primary immunodeficiencies. Nat Rev Immunol. 2016;16:702\u201314.","journal-title":"Nat Rev Immunol"},{"key":"1218_CR4","first-page":"245","volume":"3","author":"JM Han","year":"2012","unstructured":"Han JM, Patterson SJ, Levings MK. The role of the PI3K signaling pathway in CD4(+) T cell differentiation and function. Front Immunol. 2012;3:245.","journal-title":"Front Immunol"},{"key":"1218_CR5","doi-asserted-by":"publisher","first-page":"369","DOI":"10.3389\/fimmu.2018.00369","volume":"9","author":"D Michalovich","year":"2018","unstructured":"Michalovich D, Nejentsev S. Activated PI3 kinase delta syndrome: from genetics to therapy. Front Immunol. 2018;9:369.","journal-title":"Front Immunol"},{"key":"1218_CR6","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.jaci.2016.06.021","volume":"139","author":"TI Coulter","year":"2017","unstructured":"Coulter TI, Chandra A, Bacon CM, Babar J, Curtis J, Screaton N, et al. Clinical spectrum and features of activated phosphoinositide 3-kinase \u03b4 syndrome: a large patient cohort study. J Allergy Clin Immunol. 2017;139:597\u2013606.","journal-title":"J Allergy Clin Immunol"},{"key":"1218_CR7","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.jaci.2016.03.022","volume":"138","author":"E Elkaim","year":"2016","unstructured":"Elkaim E, Neven B, Bruneau J, Mitsui-Sekinaka K, Stanislas A, Heurtier L, et al. Clinical and immunologic phenotype associated with activated phosphoinositide 3-kinase \u03b4 syndrome 2: a cohort study. J Allergy Clin Immunol. 2016;138:210\u20138.","journal-title":"J Allergy Clin Immunol"},{"key":"1218_CR8","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1007\/s10875-020-00749-y","volume":"40","author":"Y Wang","year":"2020","unstructured":"Wang Y, Chen X, Yang Q, Tang W, Jia Y, Zhou L, et al. E1021K homozygous mutation in PIK3CD leads to activated PI3K-delta syndrome 1. J Clin Immunol. 2020;40:378\u201387.","journal-title":"J Clin Immunol"},{"key":"1218_CR9","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/j.gendis.2020.04.012","volume":"8","author":"Y Wang","year":"2021","unstructured":"Wang Y, Yang Q, Chen X, Tang W, Zhou L, Chen Z, et al. Phenotypic characterization of patients with activated PI3K\u03b4 syndrome 1 presenting with features of systemic lupus erythematosus. Genes Dis. 2021;8:907\u201317.","journal-title":"Genes Dis."},{"key":"1218_CR10","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1016\/j.jaci.2018.04.022","volume":"142","author":"Y Ding","year":"2018","unstructured":"Ding Y, Zhou L, Xia Y, Wang W, Wang Y, Li L, et al. Reference values for peripheral blood lymphocyte subsets of healthy children in China. J Allergy Clin Immunol. 2018;142:970\u20133.","journal-title":"J Allergy Clin Immunol"},{"key":"1218_CR11","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1016\/j.jaip.2020.01.038","volume":"8","author":"S Fekrvand","year":"2020","unstructured":"Fekrvand S, Yazdani R, Olbrich P, Gennery A, Rosenzweig SD, Condino-Neto A, et al. Primary immunodeficiency diseases and Bacillus Calmette-Gu\u00e9rin (BCG)-vaccine-derived complications: a systematic review. J Allergy Clin Immunol Pract. 2020;8:1371\u201386.","journal-title":"J Allergy Clin Immunol Pract"},{"key":"1218_CR12","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s12016-019-08738-9","volume":"59","author":"M Jamee","year":"2020","unstructured":"Jamee M, Moniri S, Zaki-Dizaji M, Olbrich P, Yazdani R, Jadidi-Niaragh F, et al. Clinical, immunological, and genetic features in patients with activated PI3K\u03b4 syndrome (APDS): a systematic review. Clin Rev Allergy Immunol. 2020;59:323\u201333.","journal-title":"Clin Rev Allergy Immunol"},{"key":"1218_CR13","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1007\/s10875-018-0568-x","volume":"38","author":"Y Wang","year":"2018","unstructured":"Wang Y, Wang W, Liu L, Hou J, Ying W, Hui X, et al. Report of a Chinese cohort with activated phosphoinositide 3-kinase \u03b4 syndrome. J CLIN IMMUNOL. 2018;38:854\u201363.","journal-title":"J CLIN IMMUNOL"},{"key":"1218_CR14","unstructured":"Global tuberculosis report 2020. Geneva: World Health Organization; 2020. Licence: CC\u00a0BY-NC-SA\u00a03.0\u00a0IGO.:58."},{"key":"1218_CR15","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/978-0-387-72005-0_8","volume":"601","author":"E Galkina","year":"2007","unstructured":"Galkina E, Kondratenko I, Bologov A. Mycobacterial infections in primary immunodeficiency patients. Adv Exp Med Biol. 2007;601:75\u201381.","journal-title":"Adv Exp Med Biol"},{"key":"1218_CR16","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1111\/imr.12272","volume":"264","author":"S Boisson-Dupuis","year":"2015","unstructured":"Boisson-Dupuis S, Bustamante J, El-Baghdadi J, Camcioglu Y, Parvaneh N, El AS, et al. Inherited and acquired immunodeficiencies underlying tuberculosis in childhood. Immunol Rev. 2015;264:103\u201320.","journal-title":"Immunol Rev"},{"key":"1218_CR17","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.clim.2015.12.008","volume":"178","author":"M Chiriaco","year":"2017","unstructured":"Chiriaco M, Brigida I, Ariganello P, Di Cesare S, Di Matteo G, Taus F, et al. The case of an APDS patient: defects in maturation and function and decreased in vitro anti-mycobacterial activity in the myeloid compartment. Clin Immunol. 2017;178:20\u20138.","journal-title":"Clin Immunol"},{"key":"1218_CR18","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1111\/imr.12790","volume":"291","author":"S Preite","year":"2019","unstructured":"Preite S, Gomez-Rodriguez J, Cannons JL, Schwartzberg PL. T and B-cell signaling in activated PI3K delta syndrome: from immunodeficiency to autoimmunity. Immunol Rev. 2019;291:154\u201373.","journal-title":"Immunol Rev"},{"key":"1218_CR19","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s40272-019-00337-7","volume":"21","author":"M Bevacqua","year":"2019","unstructured":"Bevacqua M, Baldo F, Pastore S, Valencic E, Tommasini A, Maestro A, et al. Off-label use of sirolimus and everolimus in a pediatric center: a case series and review of the literature. Paediatr Drugs. 2019;21:185\u201393.","journal-title":"Paediatr Drugs"},{"key":"1218_CR20","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/ni.2771","volume":"15","author":"CL Lucas","year":"2014","unstructured":"Lucas CL, Kuehn HS, Zhao F, Niemela JE, Deenick EK, Palendira U, et al. Dominant-activating germline mutations in the gene encoding the PI(3)K catalytic subunit p110\u03b4 result in T cell senescence and human immunodeficiency. Nat Immunol. 2014;15:88\u201397.","journal-title":"Nat Immunol"},{"key":"1218_CR21","doi-asserted-by":"publisher","first-page":"543","DOI":"10.3389\/fimmu.2018.00543","volume":"9","author":"ME Maccari","year":"2018","unstructured":"Maccari ME, Abolhassani H, Aghamohammadi A, Aiuti A, Aleinikova O, Bangs C, et al. Disease evolution and response to rapamycin in activated phosphoinositide 3-kinase \u03b4 syndrome: the European Society for Immunodeficiencies-Activated Phosphoinositide 3-Kinase \u03b4 Syndrome Registry. Front Immunol. 2018;9:543.","journal-title":"Front Immunol"},{"key":"1218_CR22","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/acel.12405","volume":"15","author":"AS Arriola","year":"2016","unstructured":"Arriola AS, Neuman JC, Baar EL, Syed FA, Cummings NE, Brar HK, et al. Alternative rapamycin treatment regimens mitigate the impact of rapamycin on glucose homeostasis and the immune system. Aging Cell. 2016;15:28\u201338.","journal-title":"Aging Cell"},{"key":"1218_CR23","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1126\/science.1215135","volume":"335","author":"DW Lamming","year":"2012","unstructured":"Lamming DW, Ye L, Katajisto P, Goncalves MD, Saitoh M, Stevens DM, et al. Rapamycin-induced insulin resistance is mediated by mTORC2 loss and uncoupled from longevity. Science. 2012;335:1638\u201343.","journal-title":"Science"},{"key":"1218_CR24","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/j.cell.2017.02.004","volume":"168","author":"RA Saxton","year":"2017","unstructured":"Saxton RA, Sabatini DM. mTOR signaling in growth, metabolism, and disease. Cell. 2017;168:960\u201376.","journal-title":"Cell"},{"key":"1218_CR25","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/nri.2017.1","volume":"17","author":"DW Cain","year":"2017","unstructured":"Cain DW, Cidlowski JA. Immune regulation by glucocorticoids. Nat Rev Immunol. 2017;17:233\u201347.","journal-title":"Nat Rev Immunol"},{"key":"1218_CR26","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.3389\/fimmu.2018.02043","volume":"9","author":"TI Coulter","year":"2018","unstructured":"Coulter TI, Cant AJ. The treatment of activated PI3K\u03b4 syndrome. Front Immunol. 2018;9:2043.","journal-title":"Front Immunol"},{"key":"1218_CR27","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1111\/cei.12706","volume":"183","author":"M Elgizouli","year":"2016","unstructured":"Elgizouli M, Lowe DM, Speckmann C, Schubert D, H\u00fclsd\u00fcnker J, Eskandarian Z, et al. Activating PI3K\u03b4 mutations in a cohort of 669 patients with primary immunodeficiency. Clin Exp Immunol. 2016;183:221\u20139.","journal-title":"Clin Exp Immunol"},{"key":"1218_CR28","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S1734-1140(11)70575-8","volume":"63","author":"AB Pithadia","year":"2011","unstructured":"Pithadia AB, Jain S. Treatment of inflammatory bowel disease (IBD). Pharmacol Rep. 2011;63:629\u201342.","journal-title":"Pharmacol Rep"},{"key":"1218_CR29","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.jaci.2018.04.032","volume":"143","author":"T Okano","year":"2019","unstructured":"Okano T, Imai K, Tsujita Y, Mitsuiki N, Yoshida K, Kamae C, et al. Hematopoietic stem cell transplantation for progressive combined immunodeficiency and lymphoproliferation in patients with activated phosphatidylinositol-3-OH kinase \u03b4 syndrome type 1. J Allergy Clin Immunol. 2019;143:266\u201375.","journal-title":"J Allergy Clin Immunol"},{"key":"1218_CR30","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1016\/j.jaci.2016.09.040","volume":"139","author":"Z Nademi","year":"2017","unstructured":"Nademi Z, Slatter MA, Dvorak CC, Neven B, Fischer A, Suarez F, et al. Hematopoietic stem cell transplant in patients with activated PI3K delta syndrome. J Allergy Clin Immunol. 2017;139:1046\u20139.","journal-title":"J Allergy Clin Immunol"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-022-01218-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10875-022-01218-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-022-01218-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,3]],"date-time":"2022-06-03T16:12:01Z","timestamp":1654272721000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10875-022-01218-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,16]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["1218"],"URL":"https:\/\/doi.org\/10.1007\/s10875-022-01218-4","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,16]]},"assertion":[{"value":"8 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was performed following the Declaration of Helsinki and improved by the ethics committee of Children\u2019s Hospital of Chongqing Medical University (Chongqing, China). Written informed consents for involvement in this study were provided by parents.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Written informed consent was obtained from individual or guardian participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Written informed consent was obtained from individual or guardian participants.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}